Sign In
Buy AGRX
$1.51
+0 (+0%)
At Close: Nov 25, 2024
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
09:29am, Tuesday, 23'rd Jan 2024
Implementation of the New Guidance Could Eliminate Financial Barriers for Contraceptive Products like Twirla® for 49 Million Women
The Company Commends House Committee on Oversight and Accountability Ranking Member Jamie Raskin for New Report on Contraception Coverage Gaps
Top Penny Stocks To Buy Now? 4 To Watch Under $4
01:30pm, Monday, 04'th Dec 2023
Whether you subscribe to the idea that penny stocks are always a buy or determine your strategy based on broader market conditions, chances are that cheap stocks are on your watch list. While these sw
Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
09:00am, Wednesday, 22'nd Nov 2023
PRINCETON, NJ / ACCESSWIRE / November 22, 2023 / Agile Therapeutics, Inc. (NASDAQ:AGRX), the commercial-stage women's healthcare company, posted a 122% increase in third-quarter revenue year-over-year
Agile Therapeutics, Inc. (AGRX) Q3 2023 Earnings Call Transcript
01:14pm, Thursday, 09'th Nov 2023
Agile Therapeutics, Inc. (AGRX) Q3 2023 Earnings Call Transcript
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
08:05am, Thursday, 09'th Nov 2023
Twirla Delivers Third Quarter 2023 Net Revenue of $6.7 Million, a 21% Increase from Second Quarter 2023 Company Announces It Expects to Generate Positive Cash Flow from Operations in First Quarter 202
Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023
08:05am, Thursday, 26'th Oct 2023
Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J.
Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Wednesday, 04'th Oct 2023
PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the granting of a previously disclosed inducement award to the
Why Shares of Agile Therapeutics Jumped This Week
04:19pm, Thursday, 28'th Sep 2023
Agile is seeing strong revenue growth. The company only has one marketed product, a birth control patch.
Agile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Group
09:00am, Thursday, 28'th Sep 2023
PRINCETON, NJ / ACCESSWIRE / September 28, 2023 / Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the
Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08:05am, Tuesday, 05'th Sep 2023
PRINCETON, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairperson and Chief Executive Officer Al Altomari and
Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023
08:30am, Wednesday, 26'th Jul 2023
PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2023 financial results before t
Agile Therapeutics, Inc. (AGRX) Q1 2023 Earnings Call Transcript
07:09pm, Friday, 12'th May 2023
Agile Therapeutics, Inc. (NASDAQ:AGRX ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Matt Riley - Head, Investor Relations Al Altomari - Chairman & Chief Executive Off
Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023
08:00am, Monday, 08'th May 2023
PRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2023 financial results after the
Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET
